bone or addition of moieties such as sugars. Formation 1 School of Biosciences of hybrid PKS systems to produce novel products has University of Birmingham been extensively reviewed [4-7]. There have been fewer Edgbaston examples of manipulation of the tailoring genes, but the Birmingham B15 2TT recent production of prerapamycin provides a powerful United Kingdom example [8]. Rational use of this approach depends on 2 School of Chemistry understanding the role of each enzyme in the biosyn-University of Bristol thetic cluster. Cantock's Close Mupirocin, a polyketide-derived antibiotic produced Bristol BS8 1TS by Pseudomonas fluorescens NCIMB10586, inhibits United Kingdom isoleucyl-tRNA synthase and is used to control infections by methicillin-resistant Staphylococcus aureus, MRSA [9]. The mupirocin structure consists of two ele-Summary ments, monic acid (MA) and 9-hydroxy-nonanoic acid (1, 9-HN), joined by an ester linkage [10-12] (Figure 1). Mupirocin, a polyketide-derived antibiotic from Pseu-Analysis of the fate of isotopically labeled precursors domonas fluorescens NCIMB10586, is a mixture of [13, 14] gave rise to a plausible biosynthetic pathway pseudomonic acids (PA) that target isoleucyl-tRNA for the primary carbon chain of monic acid that fits well synthase. The mup gene cluster encodes both type with the biosynthetic enzyme activities predicted from I polyketide synthases and monofunctional enzymes the DNA sequence of the cluster (Figure 2) [15]
Figure 1. The Structures of the Major Pseudomonic Acids
Pseudomonic acid A (PA-A) (compound 1) forms 90% ; PA-B (compound 2) forms 8%; PA-C (compound 3) forms <2% ; and PA-D (compound 4) forms <0.2%. pantetheinyl transferase, respectively), and at the down-any is active will involve considerable work-the most obvious candidate is encoded on the opposite strand stream end by the transcriptional terminator after mupX. Deletions of mupR and mupS in this region have to most other genes in the cluster, but it is not clear if it will be expressed. Therefore mupO, mupQ, mupT, previously been reported to result in complete loss of antibiotic production [15] [16] [17] [18] . The mupP region was not mupU, mupV, mupW, and mupX were selected for genetic analysis followed by identification of intermedi-targeted in this study because establishing which orf if ates that might be produced with HPLC, mass spec-sert these deletions into the chromosome as described in Experimental Procedures [15] . Antibiotic production trometry, and then NMR spectroscopy in selected by the mutants was evaluated with the plate bioassay cases. The results show that the genes encode late bio-(see Experimental Procedures), which assessed the synthetic steps and suggest that multiple genes may ability of the experimental strains to produce mupirwork together to catalyze individual tailoring steps. ocin, indicated by the average area in cm 2 of their zone of inhibition relative to the size of wild-type zone. The Results wild-type strain gave an average area of 10.1 cm 2 , and a mutant strain, AKE3 (⌬mupI) [18] , used as a "nonpro-All Genes Clustered at the Downstream End ducer" control, gave an average halo area of 1.8 cm 2 . of the mup Region Are Required for Normal Each mutant demonstrated reduced antibiotic activity Mupirocin Biosynthesis to varying extents (Figure 4 ) with ⌬mupQ and ⌬mupT In-frame chromosomal deletions were constructed in effectively indistinguishable from ⌬mupI. The mutant each of the selected genes-mupO encoding a putative bioassay phenotypes split into two groups. The first cytochrome P450 (339 codons were deleted leaving a group, containing mutants ⌬mupQ, ⌬mupT, ⌬mupW, polypeptide of 116 aa), mupQ encoding a putative acyland ⌬mupX, showed a smaller but clear halo. The sec-CoA synthase (145 codons were deleted leaving a polyond group, containing ⌬mupO, ⌬mupU, and ⌬mupV, peptide of 307 aa), mupT encoding a putative ferregave a halo with two distinct regions-a central clear doxin dioxygenase (58 codons were deleted leaving a zone surrounded by a more diffuse zone. The ⌬macpE polypeptide of 59 aa), mupU encoding a second putamutant gave a plate assay phenotype indistinguishable tive acyl-CoA synthase (501 codons were deleted leavfrom this second group (data not shown). ing a polypeptide of 24 aa), mupV encoding a putative Although the mutations were designed not to disrupt oxidoreductase (596 codons were deleted leaving a transcription or translation of the remainder of the tarpolypeptide of 67 aa), mupW encoding a putative diget genes, it is possible that the deletions also reduced oxygenase (350 codons were deleted leaving a polythe expression of downstream genes (a "polar effect") peptide of 114 aa), and mupX encoding a putative amiin the mup operon, giving a false phenotype. Therefore, dase or hydrolase (415 codons were deleted leaving a it was necessary to determine whether the mutations polypeptide of 98 aa). As part of a separate study of could be complemented in trans. All genes of interest the acyl carier proteins (to be published fully elsewhere) were cloned separately into an IncQ-based expression macpE was also inactivated in a similar manner, deletvector (pJH10) as described in Experimental Proceing 71 codons to leave a polypeptide of just 6 aa from dures. Plasmid pJH10 contains a tac promoter, an oriT the start and 3 aa from the end of the protein. It is inregion, a multiple cloning site, and a tetracycline resiscluded here because of the phenotype it generates as tance gene. The results of these complementation described below. In-frame deletions were made to ministudies were evaluated with the plate bioassay (see Exmize polar effects so that the resulting phenotype perimental Procedures) on agar with and without IPTG. should be the result of specifically knocking out the tar-Inhibition zone sizes were compared with the equivaget gene (or genes) and not because of the decreased lent strains carrying just the expression vector. Antibiexpression of downstream, nontarget genes. The speotic production was restored in all the mutants by their cific deletions in the target genes were created berespective genes cloned in trans, indicating that the detween two flanking arms, each at least 500 bp in length letions did not have secondary effects. The strains as described in Experimental Procedures.
⌬mupQ, ⌬mupW, and ⌬mupX exhibited better complementation (i.e., bigger zones of inhibition) in the ab-A suicide vector system, pAKE604, was used to in- With wild-type taken as 100%, the relative size of the zone of inhibition is indicated. The mutants are grouped by phenotype-⌬mupO, ⌬mupU, and ⌬mupV give a diffuse edge, whereas ⌬mupQ, ⌬mupT, ⌬mupW, and ⌬mupX give a clear/distinct edge. The data is the mean of three measurements. Standard deviations were of the order of 6% to 10% so that the large differences are significant, whereas the small ones are not. sence of IPTG, suggesting that low levels of expression (possibly from inefficient translation because it is likely that most if not all the genes are in the same transcriptional unit) (J.H. and C.M.T., unpublished data) are optimal for gene function. However, for ⌬mupO, ⌬mupT, and ⌬mupV, complementation was better in the presence of IPTG, indicating that a higher level of gene expression is optimal. In the absence of IPTG, macpE in trans restored mupirocin production to wt levels (100%), whereas in the presence of 0.1 mM and 0.5 mM IPTG, the zones of inhibition were slightly reduced (85%) when compared to wt.
Because sequence alignments suggest that both MupQ and MupU may have acyl-CoA ligase activities, it was possible that they might be able to substitute for each other. Because knocking out each one individually resulted in different but significant defects in antibiotic production, there clearly is not complete functional redundancy between them. Nevertheless, we created a double mutant to check whether this gave a more severe defect compared to either knock out alone. The phenotype of the ⌬mupQU double mutant in the plate bioassay is indistinguishable from that of the single ⌬mupQ mutation that gives the more severe of the two mutant phenotypes, suggesting that they do not provide alternative ways of achieving the same step. This was confirmed by overproducing mupU in trans to ⌬mupQ and overproducing mupQ in trans to ⌬mupU, which showed no evidence for any cross complementation between these two genes.
HPLC Analysis of the Products of the WT and Mutant Strains
The HPLC profile of the supernatant from stationary phase cultures of wt NCIMB10586 strain under the conditions described in Experimental Procedures and with detection at 233 nm (Figure 5) revealed one major peak 
2-PA-B, 2 in Figure 1). A very small peak was also
Analysis of the product (or products) of ⌬mupT and ⌬mupW was more complicated because the total detected at the same position as peak 2 in the profile from the negative control, AKE3(⌬mupI), which is de-amount of material that accumulated was considerably less than in the mutants described in the previous para-fective in expression of the mupirocin biosynthetic pathway [18] . It is likely that some other material also graph. Apart from a small signal corresponding to peak 2, these two mutants showed a new peak at a retention elutes at this position. Analysis of PA-A peak area by HPLC was carried out time about 0.5 min slower than PA-A, close to but not identical to peak 1. MS and NMR analysis of the com-for samples taken at different times during growth in mupirocin production medium (MPM) at 22°C after 20-pound isolated from ⌬mupW showed that this product (PA-W) did not correspond to any of the previously de-fold dilution of the overnight culture. Mupirocin production had already begun when sampling commenced at fined PAs but possesses a novel PA structure 10 ( Figure  6 ), which lacks the characteristic tetrahydropyran ring 8 hr, but between 8 and 13 hr, a rapid increase in pseudomonic acid production was observed. Maximum an-common to all known pseudomonic acids. Detailed structural analysis is described fully elsewhere [19] . tibiotic production (w0.8 g/ml) was reached at approximately 15 hr, and from this point, levels of PA-A remained relatively constant. The negative control pro-Discussion duced only a negligible amount of PA-A throughout the experiment. Therefore, the supernatants of mutant cul-The genes mupO, mupQ, mupS, mupT, mupU, mupV, tures were analyzed at 30 hr. HPLC traces from the mupW, and mupX were all proposed to be required for broth of the ⌬mupX strain showed a similar profile to tailoring the core structure produced by the type I PKS wt but with a smaller area under peak 1 (approximately assembly line. Combined with the data presented pre-85% relative to wt peak 1).
viously [15] , the results in this paper confirm that in-The HPLC traces from the broths of ⌬mupO, ⌬mupU, deed all mutations studied do affect mupirocin producand ⌬mupV strains all showed the same profile in which tion. The effect of the deletion in mupX is the weakest, peak 1 was absent and peak 2 at 19.55 min was now a simply resulting in an approximately 15% decrease in similar size to peak 1 in supernatants from wt (70%, production of PA-A. It therefore appears that MupX is 78%, and 122%, respectively, relative to wt peak 1). The not essential for any step in the biosynthesis but some-⌬macpE mutant showed the same profile as these muhow modifies either the expression of the genes or the tants with peak 2 being approximately 60% relative to efficiency with which enzymes of the pathway proceed. the size of wt peak 1. Based on area of zones of inhibi-
The blast hits and sequence alignments suggest that tion, the ⌬macpE mutant exhibits 64% antibacterial ac-MupX may have amidase/hydrolase activity. It is postivity when compared to wt. ⌬mupT and ⌬mupW broths sible that MupX represents a relic of an activity that is typically showed similar peak profiles to each other, no longer required but remains because the protein is with only small amounts of detectable material (22% still a structural component of a multienzyme assembly and 17%, respectively, relative to wt). Two peaks were essential for mupirocin production. In this regard, it may detected that elute slightly later than peaks 1 and 2 be significant that the thiomarinols have an amide de-(retention time 20.59 min and 19.61 min, respectively). rivative at C-1# ( Figure 2 ). One can suggest, therefore, Finally, ⌬mupQ, ⌬mupQU, and ⌬mupS (whose plate that MupX may have had a role in removing an amide bioassay phenotype was reported previously [15] ) typiderivative. cally showed less than 10% the level of detectable An important part of our analysis was to demonstrate material relative to wt, and this was concentrated at the that each of the mutants could be complemented, position of peak 2. Additional peaks detected at 233
showing that the phenotype of the mutation was not nm with faster or slower elution were sometimes obbecause of polar effects. All of the mutants could be served for these mutant strains and will eventually be complemented, but the level of induction of the tac proanalyzed in detail. However, in this study, we concenmoter by addition of IPTG that was optimal for completrated on the most obvious peaks. mentation varied. It is well known that the tac promoter control is leaky, so it is to be expected that there will be a basal level of expression of all the cloned genes
Mass Spectrometric and NMR Analysis of the Products of Selected Mutants
in the absence of IPTG. Whether or not addition of IPTG is necessary may reflect differences in the efficiency of The calculated relative molecular mass (M r ) of PA-A is 500. The mass spectra of the PA-A standard and PA-A expression of the cloned genes or may indicate the levels of proteins normally needed for PA production as purified from the wt broth show very similar profiles. The major peak in both has an M r of 523, which corres-well as differences in the consequences of overproduction. Complemented strains in which antibiotic levels ponds to the sodium adduct of PA-A (500 + 23). The spectra of the purified compound from peak 2 pro-are reduced in the presence of IPTG might be expressing proteins that are either toxic to the cell or inhibit the duced by ⌬mupO, ⌬mupU, ⌬mupV, and ⌬macpE showed a major peak with an M r of 517, corresponding synthesis of mupirocin when expressed at high levels.
Mutation of mupW results in the formation of a new to the hydrogen adduct of PA-A plus an oxygen atom [16] . NMR spectral analysis of this material confirmed metabolite, which we have shown to have the structure 10 ( Figure 5 ) lacking the characteristic tetrahydropyran the structure as PA-B when compared with values from the literature [12] . The major product of ⌬mupX (peak ring found in the pseudomonic acids and thiomarinols [19] . One possibility is that pseudomonic acid W (10) is 1) was confirmed as PA-A by mass spectrometry and NMR.
formed from an acyclic biosynthetic intermediate, e.g., posed, therefore, that the biosynthetic step being affected by these mutations is initiated by MupU loading 5-hydroxylation, 10,11-epoxidation, and esterification with 9-HN still take place. This implies that it is not mAcpE with an intermediate, which is then modified by MupO, supported by MupV (Figure 7) . essential for MA synthesis to be completed before esterification with 9-HN. MupT may also be involved in Where in the biosynthetic scheme might this mAcpE-MupU-O-V complex work? According to the predicted this step but has not yet been characterized in more detail. mupirocin biosynthetic pathway [15] , PA-A would result from epoxidation of PA-C 3 (Figure 1) . PA-B would then Of the remaining mutations that generate phenotypes, the most obvious is that exhibited by ⌬mupO, originate from a simple hydroxylation of PA-A at C8, a commonly observed process in secondary metabolism. ⌬mupU, ⌬mupV, and ⌬macpE, which knock out production of PA-A and shift the pathway into producing However, the accumulation of PA-B at the cost of PA-A production in the mutants reported here indicates that an equivalent or greater amount of PA-B (80%, 87%, 137%, and 60% relative to wt, respectively). This could
PA-B can not be derived as previously proposed. Indeed, radio-labeling studies conducted by Mantle et al. suggest that the protein products of these genes are all involved in the same biosynthetic step. MupO is a [25] were also inconsistent with the model that PA-B arises from the oxidation of PA-A. Although it is pos-putative P450 monooxygenase. P450s commonly catalyze reactions involving oxygen transfer, which are typi-sible that PA-A may be derived by direct deoxygenation of PA-B, the observed efficient switching from PA-A to cal in post-PKS tailoring. Cytochrome P450 monooxygenases are often found in PKS gene clusters, and PA-B production can perhaps be best explained by diversion of intermediate flux at a key branchpoint (Figure there are many cases of their inactivation leading to a structure related to the native antibiotic but lacking a 7). The polyketide precursor 11 predicted from the domain structure of the mupirocin PKS retains an olefinic hydroxyl or epoxide group. For example, the disruption of pimD, a gene encoding a P450 monoxygenase in the double bond between carbons 8 and 9. This must be reduced to attain the correct overall oxidation level of pimaricin gene cluster (S. natalensis), results in the formation of 4,5-deepoxypimaricin [20]. In erythromycin PA-A. In a fully processive pathway, this reduction would be predicted to occur via an enoyl reductase biosynthesis, inactivation of eryF leads to the accumulation of a derivative lacking the hydroxyl group at C-6 (ER) at the tetraketide stage, but the appropriate condensation module 3 lacks an ER domain [15]. The re-(6-deoxyerythromycin A) [21]. Some atypical reactions performed by P450s have been reported, however, in-
duction must therefore be carried out by a reductase outside the PKS, and a number of candidate genes can cluding reductions, dehydrations, dehydrogenations, and isomerizations [22] . Another common feature of P450s be identified in the mup cluster, e.g., mupC, mupE, and mupV. The timing of this essential reduction step is, is that they function as a part of multicomponent systems, requiring electron transport proteins to shuttle elec-however, not apparent. It is relevant to this that the lovastatin nonaketide synthase encoded by lovA lacks a trons from NAD(P)H [23] . Such a role could be provided by MupV, which is predicted to possess NADPH-functioning ER domain, and this activity is supplied by a separate gene, lovC. Expression of lovA in the ab-dependent reductase activity. MupU is a putative acyl-CoA ligase, the obvious role for which would be activa-sence of lovC results in accumulation of nonreduced 
In branch one, the MupO-U-V-mACPE complex catalyzes the reduction of the C8-C9 alkene bond so that the subsequent action of
MupW produces a hydroxyl at C16, which then cyclizes to produce the pyran ring. In the absence of the reduction step, isomerization leads to a C8-C16 alkene that produces an epoxide ring with the action of MupW, eventually leading to the PA-B structure as shown.
shunt products [26] . We would thus suggest that the
Significance putative MupO-MupU-MupV-mAcpE complex is involved in this key reduction step and so controls the
The mupirocin biosynthetic cluster has a number of flux of intermediates down this channel. Although there unusual features that distinguish it from many preare a number of possibilities, the timing of its intervenviously studied polyketide biosynthetic pathways. It tion would likely be at the end of PKS assembly, or conmay thus provide an alternative model system appliceivably after addition of 9-HN. Subsequent post-PKS cable to other natural products such as the thiomaritailoring steps including MupW-initiated cyclisation nols. The role of the tailoring genes is the least pre- (Figure 7 ) would lead to PA-A. Disruption of the full dictable part of the scheme. This analysis of a functionality of this complex by any of the reported muselected group of mup genes is of great significance tations would lead to PA-B. At this stage, we can only in linking genes to biosynthetic function and has speculate on the mechanism and the genes involved, prompted us to propose a testable hypothesis for key but an interesting possible mechanism would be isomsteps leading to the formation of the central pyran erization of the 8,9-olefin 11 to give the 8,16-isomer 13. ring in monic acid. This provides an explanation for Subsequent epoxidation to 14, perhaps also catalyzed the synthesis of the two major pseudomonic acids, A by MupW, would allow an alternative mechanism of and B. Although in this paper we have focused on tetrahydropyran-ring closure, which would form the the mutations that cause the most identifiable shift in tetrahydropyran ring and introduce the 8-hydroxyl in biosynthesis, we also report that the mupW mutant, one step as shown. The resulting intermediate 15 would which accumulates much less intermediate, is neverrequire efficient conversion by the remaining tailoring theless informative. A challenge for the future is to enzymes to produce PA-B in comparable yields to determine whether there are minor peaks in other muthose of PA-A observed in the wt strain. A muchtants that can also be informative. (Pn) (150 g/ml in liquid and 300 g/ml in solid medium), ampicillin vector was designated pSC⌬O. The mutants ⌬mupT, ⌬mupV, (Ap) (50 g/ml); kanamycin (Km) (50 g/ml); tetracycline (Tc) (25g/ ⌬mupW, and ⌬mupX were also constructed with the same cloning ml); and mupirocin (Mup) (500 g/ml). and integration strategy used to generate 10586⌬mupO but with primers as listed in Table S1 , with the nomenclature as for mupO.
DNA Isolation and Manipulation
Plasmid DNA was isolated by the alkaline/SDS lysis method [31] .
Construction of Expression Plasmids and Complementation For higher quality plasmid DNA extraction, the Wizard plus SV miniof Deletion Mutants prep purification system manufactured by Promega was used in
The ORFs for each of the genes studied were amplified with the accordance with the manufacturer's guidelines. A yeast DNA miniprimers listed in Table S1 . These primers placed an EcoRI site imprep kit manufactured by Nucleon Tepnel Life Sciences was used to isolate high quality chromosomal DNA. Restriction enzymes mediately upstream of the start codon and a SacI site immediately were purchased from Gibco BRL, MBI-Fermentas, and New Endownstream of the stop codon. After initial cloning into pGEMTgland Biolabs (NEB) and used according to the manufacturer's easy vector, the amplified DNA was checked by sequencing. The guidelines. Digested DNA was analyzed by agarose gel electropho-EcoRI-SacI fragment was then ligated between the EcoRI and SacI resis in 1× TAE by standard procedures [32] . DNA fragments were sites of the Tc R vector pJH10 [15] , placing it downstream of the purified with the "Geneclean kit" from Bio101. T4 DNA ligase purinducible tac promoter. Each recombinant plasmid was designated chased from Gibco BRL was used for ligations and was incubated pSCC followed by the letter corresponding to the gene involved. at 4°C overnight. The ligation reaction was then transformed into
The expression plasmids were introduced into their corresponding E. coli DH5α. mutant host by biparental mating followed by appropriate selec-PCR reactions were performed as described by Mullis et al. [33] .
tion. As a control the vector, pJH10, with no inserted mup gene, Template DNA was generated by the standard boiled colony was always introduced in parallel. method. Primers were designed to flank the region of interest with extra restriction sites for cloning if needed. Primers were synthesized by Alta Bioscience, University of Birmingham. Table S1, avail-
Determination of Mupirocin Activity and Related Compounds able with this article online, lists all primers designed and used in
The plate test for antibacterial activity was performed as described this study. The DNA polymerases used were Expand High Fidelity previously [15] . For HPLC quantitative determination of the concensystem, manufactured by Boehringer Mannheim, for gene cloning trations of pseudomonic acid and its intermediates from liquid culand Taq polymerase for confirmation of chromosomal genotype.
tures, a calibration curve based on purified mupirocin standard was Glycerol was added to the diagnostic PCR reactions to a final conused. Where a standard did not exist, purified intermediates were centration of 5%. PCR product purification was achieved with a dried and weighed. 
